These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 26701795)

  • 1. Human Milk Oligosaccharides and Synthetic Galactosyloligosaccharides Contain 3'-, 4-, and 6'-Galactosyllactose and Attenuate Inflammation in Human T84, NCM-460, and H4 Cells and Intestinal Tissue Ex Vivo.
    Newburg DS; Ko JS; Leone S; Nanthakumar NN
    J Nutr; 2016 Feb; 146(2):358-67. PubMed ID: 26701795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human milk oligosaccharides 2'-fucosyllactose and 6'-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling.
    Sodhi CP; Wipf P; Yamaguchi Y; Fulton WB; Kovler M; Niño DF; Zhou Q; Banfield E; Werts AD; Ladd MR; Buck RH; Goehring KC; Prindle T; Wang S; Jia H; Lu P; Hackam DJ
    Pediatr Res; 2021 Jan; 89(1):91-101. PubMed ID: 32221473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Human Milk Oligosaccharides 3-FL, Lacto-N-Neotetraose, and LDFT Attenuate Tumor Necrosis Factor-α Induced Inflammation in Fetal Intestinal Epithelial Cells In Vitro through Shedding or Interacting with Tumor Necrosis Factor Receptor 1.
    Cheng L; Kong C; Wang W; Groeneveld A; Nauta A; Groves MR; Kiewiet MBG; de Vos P
    Mol Nutr Food Res; 2021 Apr; 65(7):e2000425. PubMed ID: 33465830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human milk oligosaccharide 2'-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation.
    He Y; Liu S; Kling DE; Leone S; Lawlor NT; Huang Y; Feinberg SB; Hill DR; Newburg DS
    Gut; 2016 Jan; 65(1):33-46. PubMed ID: 25431457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Human Milk Oligosaccharide 2'-Fucosyllactose Quenches Campylobacter jejuni-Induced Inflammation in Human Epithelial Cells HEp-2 and HT-29 and in Mouse Intestinal Mucosa.
    Yu ZT; Nanthakumar NN; Newburg DS
    J Nutr; 2016 Oct; 146(10):1980-1990. PubMed ID: 27629573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional response of HT-29 intestinal epithelial cells to human and bovine milk oligosaccharides.
    Lane JA; O'Callaghan J; Carrington SD; Hickey RM
    Br J Nutr; 2013 Dec; 110(12):2127-37. PubMed ID: 23710626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gram-scale chemical synthesis of galactosyllactoses and their impact on infant gut microbiota
    Meeusen E; Cao L; Delsing DJ; Groeneveld A; Heerikhuisen M; Schuren F; Boltje TJ
    Org Biomol Chem; 2024 Mar; 22(10):2091-2097. PubMed ID: 38363206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-chain fatty acid butyrate, a breast milk metabolite, enhances immature intestinal barrier function genes in response to inflammation in vitro and in vivo.
    Gao Y; Davis B; Zhu W; Zheng N; Meng D; Walker WA
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G521-G530. PubMed ID: 33085904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine.
    He Y; Liu S; Leone S; Newburg DS
    Mucosal Immunol; 2014 Nov; 7(6):1326-39. PubMed ID: 24691111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence and Levels of Galactosyllactoses and Other Oligosaccharides in Human Milk and Their Variation during Lactation and According to Maternal Phenotype.
    Eussen SRBM; Mank M; Kottler R; Hoffmann XK; Behne A; Rapp E; Stahl B; Mearin ML; Koletzko B
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycyrrhizin Attenuates
    Xu X; Gong L; Wang B; Wu Y; Wang Y; Mei X; Xu H; Tang L; Liu R; Zeng Z; Mao Y; Li W
    Front Immunol; 2018; 9():2321. PubMed ID: 30459751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity.
    Izadpanah A; Dwinell MB; Eckmann L; Varki NM; Kagnoff MF
    Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G710-9. PubMed ID: 11254498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Milk Oligosaccharides Differently Modulate Goblet Cells Under Homeostatic, Proinflammatory Conditions and ER Stress.
    Cheng L; Kong C; Walvoort MTC; Faas MM; de Vos P
    Mol Nutr Food Res; 2020 Mar; 64(5):e1900976. PubMed ID: 31800974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactooligosaccharides protects against DSS-induced murine colitis through regulating intestinal flora and inhibiting NF-κB pathway.
    Chu H; Tao X; Sun Z; Hao W; Wei X
    Life Sci; 2020 Feb; 242():117220. PubMed ID: 31881230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β2 induces maturation of immature human intestinal epithelial cells and inhibits inflammatory cytokine responses induced via the NF-κB pathway.
    Rautava S; Lu L; Nanthakumar NN; Dubert-Ferrandon A; Walker WA
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):630-8. PubMed ID: 22067113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine colostrum inhibits nuclear factor kappaB-mediated proinflammatory cytokine expression in intestinal epithelial cells.
    An MJ; Cheon JH; Kim SW; Park JJ; Moon CM; Han SY; Kim ES; Kim TI; Kim WH
    Nutr Res; 2009 Apr; 29(4):275-80. PubMed ID: 19410980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactooligosaccharide pretreatment alleviates damage of the intestinal barrier and inflammatory responses in LPS-challenged mice.
    Wang G; Sun W; Pei X; Jin Y; Wang H; Tao W; Xiao Z; Liu L; Wang M
    Food Funct; 2021 Mar; 12(4):1569-1579. PubMed ID: 33459741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2'-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial.
    Goehring KC; Marriage BJ; Oliver JS; Wilder JA; Barrett EG; Buck RH
    J Nutr; 2016 Dec; 146(12):2559-2566. PubMed ID: 27798337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.